[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100502433":3},{"organization":4,"armGroups":7,"interventions":13,"overallOfficials":10,"centralContacts":18,"locations":28,"responsibleParty":43,"collaborators":45,"id":49,"slug":10,"hasResults":50,"nctId":51,"briefTitle":52,"officialTitle":52,"acronym":10,"eligibilityCriteria":53,"healthyVolunteers":54,"sex":55,"minAge":56,"maxAge":10,"enrollmentInfo":57,"targetDuration":10,"studyType":60,"phases":10,"briefSummary":61,"conditions":62,"keywords":10,"overallStatus":30,"whyStopped":10,"lastUpdateSubmitDate":64,"lastUpdatePostDateStruct":65,"startDateStruct":68,"completionDateStruct":70,"leadSponsor":72,"locationsCount":73},{"fullName":5,"class":6},"Inova Medical","OTHER",[8],{"label":9,"type":10,"description":10,"interventionNames":11},"Individuals with COVID-19 diagnosis during the SARS-CoV-2 omicron wave in Brazil",null,[12],"Other: Multiple exposures",[14],{"type":6,"name":15,"description":16,"armGroupLabels":17,"otherNames":10},"Multiple exposures","Exposures variables (observational study): age, gender, education, comorbidities, vaccination status, severity of the acute episode of COVID-19, treatments used for acute COVID-19.",[9],[19,24],{"name":20,"role":21,"phone":22,"phoneExt":10,"email":23},"Maicon Falavigna, MD, PhD","CONTACT","+5551994408818","maicon@inovamedical.com.br",{"name":25,"role":21,"phone":26,"phoneExt":10,"email":27},"Régis G Rosa, MD, PhD","+5551991303877","regis@inovamedical.com.br",[29],{"facility":5,"status":30,"city":31,"state":32,"zip":10,"country":33,"cosmosGeoPoint":34,"geoPoint":39,"contacts":40},"RECRUITING","Cachoeirinha","Rio Grande do Sul","Brazil",{"type":35,"coordinates":36},"Point",[37,38],-51.09389,-29.95111,{"lat":38,"lon":37},[41],{"name":42,"role":21,"phone":10,"phoneExt":10,"email":10},"Maicon Falavigna",{"type":44,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[46],{"name":47,"class":48},"Merck Sharp & Dohme LLC","INDUSTRY","100502433",false,"NCT05822193","Incidence, Associated Factors, and Burden of Post COVID-19 Condition in Brazil","Inclusion Criteria:\n\n* Age ≥ 18 years;\n* Brazilian resident;\n* Symptomatica COVID-19 confirmed by reverse transcriptase polymerase chain reaction (RT-PCR) or antigen test for SARS-COV-2 after January 2022, with diagnosis at least 90 days before recruitment.\n\nExclusion Criteria:\n\n* No availability to participate in remote research appointments;\n* Communication difficulty (aphasia, important hearing loss, non-portuguese speaker, severe dementia)\n* Refuse to provide informed consent",true,"ALL","18 Years",{"count":58,"type":59},1694,"ESTIMATED","OBSERVATIONAL","This is a national retrospective cohort study with internet-based recruitment which intends to enroll 1,694 adult patients with COVID-19 diagnosis during the SARS-CoV-2 omicron wave in Brazil. Participants with confirmed symptomatic COVID-19 after january 2022 will be evaluated in order to assess incidence, potential risk factors and impact of post COVID-19 condition according to the WHO definition on health-related quality of life and other relevant patient-centered outcomes.",[63],"Post-Acute COVID-19 Syndrome","2025-02-17",{"date":66,"type":67},"2025-02-19","ACTUAL",{"date":69,"type":67},"2023-07-21",{"date":71,"type":59},"2025-07-31",{"name":5,"class":6},1]